Skip to main content

Table 16 The cost-effectiveness analysis in the 12-month intervention period (the reversion rate)

From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

Group C (yuan) E (%) C/E ΔC/ΔE
The treatment group 22967057.6 41.8 549451.1  
The control group 20425193.3 27.8 734719.2 181561.7